← Leaderboards
Fay Kastrinos
Columbia University Health Sciences
$2,304,301
Attributed
$4,210,740
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,210,740 · 3
By mechanism
R01$3,355,604 · 2
K07$855,136 · 1
Top collaborators
- Chin Hur7 shared
- Sonia Kupfer2 shared
- Elena Martinez Stoffel2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Richard J Baer$14,462,602
- Mary Beth Terry$27,685,500
- Sarah Colonna$0
- Eric C Greene$16,539,943
- Nathalie Moise$9,812,522
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesHereditary Nonpolyposis Colorectal NeoplasmsMalignant NeoplasmsColorectal CancerLifetime RiskIncidenceMismatch RepairCohortInheritedAffectHealth PersonnelRisk FactorsMutation CarrierProviderMsh6 GeneMlh1 GeneHereditary Breast And Ovarian Cancer SyndromeSyndromeCancer PreventionCancer ControlMsh2 GeneAdherenceAttitudeColorectal Cancer Screening
Grant awards (14)
FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trial$669,912
R01 · FY2025 · CA
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$372,279
R01 · FY2025 · CA
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$70,872
R01 · FY2025 · CA
FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trial$701,911
R01 · FY2024 · CA
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$353,665
R01 · FY2024 · CA
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$70,872
R01 · FY2024 · CA
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$364,833
R01 · FY2023 · CA
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$366,520
R01 · FY2022 · CA
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$384,740
R01 · FY2021 · CA
Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations$171,180
K07 · FY2014 · CA · contact PI
Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations$171,180
K07 · FY2013 · CA · contact PI
Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations$171,180
K07 · FY2012 · CA · contact PI
Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations$171,180
K07 · FY2011 · CA · contact PI
Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations$170,416
K07 · FY2010 · CA · contact PI